logo
16:01 Jan 19

Fredun Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1515.00
+19.55 (+1.31%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Fredun Pharmaceuticals Ltd. Financials

Fredun Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1515.00
+19.55 (+1.31%)
16:01 Jan 19
Quality
image/svg+xml

52/100
Medium Financial Strength

Valuation
image/svg+xml

41/100
Mid Valuation

Technical

54/100
Technically Neutral

Strength

12

Weakness

2

Opportunity

1

Threats

0

14.71 %

ROE %

4.27 %

ROA %

0.00

EPS

299.47

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
224.46 274.68 348.16 453.82 530.27
Operating Expenses +
210.66 246.9 310.17 401.17 465.26
Raw Material
177.11 246.4 283.76 323.98 388.01
Increase Decrease in Cost
-0.01 -37.72 -22.44 6.05 -3.74
Other Manufacturing Expense
7.15 9.58 13.62 17.71 0
Employee Cost
10.66 11.53 12.5 22.23 31.48
Miscellaneous Expenses
15.75 17.11 22.73 31.2 49.51
Operating Profit
13.8 27.78 37.99 52.65 65.01
Other Income
1.63 1.82 0.92 2.45 4.99
Depreciation
2.16 2.81 3.8 4.45 5.36
Interest
4.67 9.28 13.65 22.38 27.41
Profit before tax and exceptio..
8.6 17.51 21.45 28.27 37.23
Exceptional Items
0 0 0 0 0
PBT
8.6 17.51 21.45 28.27 37.23
Provision for Taxation
2.26 6.7 5.83 7.46 8.31
Net Profit
6.34 10.81 15.62 20.81 28.9
NET Profit after MI
0 0 0 0 0
EPS
11.28 24.13 33.66 44.83 61.21
Operating Profit Margin (%)
6.15 10.11 10.91 11.6 12.26
Net Profit Margin (%)
2.82 3.94 4.49 4.59 5.45

Fredun Pharmaceuticals Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 48.90 48.90 48.90 48.90 48.90 49.20
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 1.60 1.60 1.60 1.60 1.60 1.60
Others 49.50 49.50 49.50 49.50 49.50 49.20
Shareholder Shares Holding %
Research 360 logo
Download Our App On: